文献速递临床试验与 GCP真实世界研究与卫生经济

Snacktivity™促进身体活动与健康结局的有效性和成本效果:多中心随机对照试验研究方案

The effectiveness and cost effectiveness of Snacktivity™ as an intervention to promote physical activity and health outcomes: a study protocol for a multi-centre randomised controlled trial.
PubMed 文献 · Trials · 2025-12-28

本研究为多中心、双臂、个体随机、平行组、优效性试验,计划纳入966名身体活动不足的成年人,比较Snacktivity™干预与常规护理对12个月时中高强度身体活动平均分钟数的影响,并评估成本效果。Snacktivity™干预包括5分钟简短咨询和基于手机应用与Fitbit设备的 technology 支持,以行为改变技术促进自我监测、习惯形成、行动计划和反馈。

要点

  • Snacktivity™鼓励以每天2-5分钟中高强度活动片段累积≥150分钟/周,并每周进行两次肌肉强化活动。
  • 主要结局为12个月随访时腕戴加速度计测量的中高强度身体活动平均分钟数组间差异。
  • 试验计划纳入966名身体活动不足的成年人,个体随机1:1分配至Snacktivity™干预组或常规护理对照组。

核心结论

  • 该试验旨在评估Snacktivity™干预相比常规护理增加身体活动并降低未来疾病风险的有效性和成本效果。

研究设计与样本

  • 多中心、双臂、个体随机、平行组、优效性试验,并包含经济学评价,计划在966名身体活动不足的成年人中开展。
  • 参与者从National Health Service Trusts and organisations以及非National Health Service场所(如社区团体和社交媒体)招募,按1:1个体随机分配至Snacktivity™干预组或常规护理对照组。

主要发现

  • 主要结局为12个月随访时通过腕戴加速度计测量的中高强度身体活动平均分钟数的组间差异。
  • 次要结局包括12个月随访时加速度计评估的每日轻度、中度和剧烈强度身体活动平均分钟数、久坐时间、体重和心理健康结局。

关键数值与推荐

  • Snacktivity™干预包含两个主要部分:关于Snacktivity™原则和目的的5分钟简短咨询;以及获得技术支持的权限(名为SnackApp的手机应用,连接Fitbit活动设备Versa 4)。
  • Snacktivity™干预通过行为改变技术促进身体活动的自我监测、习惯形成、行动计划和每日完成活动片段数量的反馈。
  • Snacktivity™方法鼓励公众在全天/周内以2-5分钟中高强度身体活动片段累积≥150分钟身体活动,并每周进行两次肌肉强化活动。

临床怎么用

  • 原文未据此给出临床推荐;研究结果可能为未来公共卫生指南和公共卫生信息提供参考,以提升公众对Snacktivity™潜在健康益处的认识。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A novel 'whole day' approach that could motivate the public to be more physically active is termed Snacktivity™. Consistent with guidance, the Snacktivity™ approach encourages the public to accumulate ≥ 150 min of physical activity in short 2-5-min 'activity snacks' of moderate-vigorous intensity physical activity throughout the day/week. Snacktivity™ also promotes muscle-strengthening activity twice per week. Following completion of research to co-design and develop the Snacktivity™ approach, the aim of this trial is to assess the effectiveness and cost-effectiveness of a Snacktivity™ intervention to increase physical activity and reduce future risk of disease in the population, compared with usual care. METHODS: A multi-centre, two-arm, individually randomised, parallel group, superiority trial, with an economic evaluation, will be conducted in 966 physically inactive adults. Participants will be recruited from National Health Service Trusts and organisations and non-National Health Service settings (e.g. community groups and social media). Participants will be individually randomized (1:1) to the Snacktivity™ intervention group or a usual care comparator group. The Snacktivity intervention involves two main components; a brief 5-min consultation about the principles and purpose of Snacktivity™; and access to technology support (mobile phone app called the SnackApp, linked to a Fitbit activity device (Versa 4)) that through behavioural change techniques promote self-monitoring of physical activity, habit formation, action planning and feedback on the number of activity snacks completed each day. The primary outcome is the difference in average minutes of moderate-vigorous physical activity between the groups at 12-months follow up, measured using a wrist worn accelerometer. Secondary outcomes include accelerometer-assessed average minutes per day of light, moderate, and vigorous intensity physical activity, time sedentary, weight and psychological health outcomes, at 12 month follow-up. DISCUSSION: Innovative interventions such as Snacktivity™, that aim to support the public to increase their physical activity each day are required. Findings could inform future public health guidance and public health messaging that seeks to raise awareness in the population of the potential benefits of Snacktivity™ for health. TRIAL REGISTRATION: ISRCTN: 12390945 . Registered on 22 March, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Daley AJ, Griffin RA, Sanders JP, et al. The effectiveness and cost effectiveness of Snacktivity™ as an intervention to promote physical activity and health outcomes: a study protocol for a multi-centre randomised controlled trial. Trials. 2025. PMID: 41456066. doi:10.1186/s13063-025-09391-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。